Rheumatology Network's Top 5: July 16, 2022


Take 5 minutes to catch up on Rheumatology Network's highlights from the week ending July 16, 2022.

Rheumatoid Arthritis Quiz: Cancer and RA

Cancer is linked to many chronic conditions, but what is its relationship with rheumatoid arthritis? Test your knowledge with this quiz.

Neutralizing Anti-Drug Antibodies Linked to Worse Disease Activity in Inflammatory Arthritis

Further research examining a possible association between smoking, which was found more frequently in nADAb-positive patients, is warranted.

Akiko Iwasaki, PhD: Exploring the Drivers of Lupus via Endogenous Retroviruses

Iwasaki and her team analyzed 3220 unique sequences of endogenous retroviruses that are a part of the human genetic make up or genome to understand if retroviruses cause or worsen this disease.

Q&A: Achieving Minimal Disease Activity in Patients with Recent-Onset Psoriatic Arthritis

In this Q&A, Rubén Queiro, MD, PhD, discussed the findings of his study that examined the variables associated with achieving minimal disease activity in patients with recent-onset psoriatic arthritis.

John K Botson MD, RPh, CCD: FDA Approval of Pegloticase Injection Plus Methotrexate for Gout Treatment

John K. Botson MD, RPh, CCD, weighs in on the recent FDA approval of pegloticase injection plus methotrexate for the treatment of uncontrolled gout.

Related Videos
Signs and Symptoms of Connective Tissue Disease
Connective Tissue Disease Brings Dermatology & Rheumatology Together
© 2024 MJH Life Sciences

All rights reserved.